Fecal Microbiota Therapy, Live-Jslm Improves HRQOL In Patients With Recurrent CDI, Research Suggests
August 16, 2023
Infectious Disease Advisor (8/15, Chan) reports that a study suggests “patients receiving biotherapeutic therapy with fecal microbiota, live-jslm for recurrent Clostridioides difficile infection experience substantial and sustained improvement in disease-...